UK - LRM and Vesalius lead EUR 10m funding for Apitope

LRM and Vesalius Biocapital have led a EUR 10m series-A round of funding for biopharmaceutical company Apitope International.

VINNOF and the University of Hasslet also invested. Apitope is a developer of vaccines and diagnostics for autoimmune and allergic diseases.

Series-A2 for Finnish startup focused on combating the climate crisis also backed by the EIB

New funding comes just seven months after a Series B, with the company doubling in value

SellerX has already raised amost EUR 250m in debt and equity in its 12 months since inception

Food startup was founded in 2020 and will use the funding to invest in technology and its expansion in Stockholm

Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017

Czech Republic-headquartered family office is targeting DACH and CEE region deals

Ex-Rocket Internet leader Bettina Curtze joins Swiss VC firm as partner and CFO

Estonia-registered VC could bolster LP base with fresh capital from funds-of-funds or pension funds